Endogenous erythropoietin protects neuroretinal function in ischemic retinopathy

American Journal of Pathology

Volumn 180, Issue 4, 2012, Pages 1726-1739

  Mowat, Freya M ^a   Gonzalez, Francisco ^a,b   Luhmann, Ulrich F O ^a   Lange, Clemens A ^a,c   Duran, Yanai ^a   Smith, Alexander J ^a   Maxwell, Patrick H ^a   Ali, Robin R ^a   Bainbridge, James W B ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^c UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN; RECOMBINANT ERYTHROPOIETIN;

A WAVE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; B WAVE; CONTROLLED STUDY; ELECTRORETINOGRAPHY; EYE; HEMATOCRIT; HETEROZYGOSITY; HYPEROXIA; KIDNEY; LIGHT EXPOSURE; MOUSE; MUELLER CELL; NERVE DEGENERATION; NIGHT VISION; NONHUMAN; OXYGEN INDUCED RETINOPATHY; PHOTOPIC VISION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RETINA DEGENERATION; RETINA ISCHEMIA; RETINA NEOVASCULARIZATION; RETINOPATHY; TRANSGENIC MOUSE; VISUAL SYSTEM FUNCTION; WILD TYPE;

ANIMALS; APOPTOSIS; CELL HYPOXIA; DISEASE MODELS, ANIMAL; ELECTRORETINOGRAPHY; ERYTHROPOIETIN; ISCHEMIA; KIDNEY; MICE; MICE, TRANSGENIC; OXYGEN; RECOMBINANT PROTEINS; RETINA; RETINAL NEOVASCULARIZATION; RETINAL NEURONS; RETINAL VESSELS; UP-REGULATION;

EID: 84859046696     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2011.12.033     Document Type: Article

References (75)

1. T. Bek Inner retinal ischaemia: current understanding and needs for further investigations Acta Ophthalmol 87 2009 362 367
2. E. Wittstrm, V. Ponjavic, M. Lvestam-Adrian, J. Larsson, S. Andréasson Electrophysiological evaluation and visual outcome in patients with central retinal vein occlusion, primary open-angle glaucoma and neovascular glaucoma Acta Ophthalmol 88 2010 86 90
3. J. Rehak, M. Rehak Branch retinal vein occlusion: pathogenesis, visual prognosis, and treatment modalities Curr Eye Res 33 2008 111 131
4. P. Sapieha, J.S. Joyal, J.C. Rivera, E. Kermorvant-Duchemin, F. Sennlaub, P. Hardy, P. Lachapelle, S. Chemtob Retinopathy of prematurity: understanding ischemic retinal vasculopathies at an extreme of life J Clin Invest 120 2010 3022 3032
5. D.M. Rosenbaum, P.S. Rosenbaum, A. Gupta, M.D. Michaelson, D.H. Hall, J.A. Kessler Retinal ischemia leads to apoptosis which is ameliorated by aurintricarboxylic acid Vision Res 37 1997 3445 3451
6. A.B. Fulton, R.M. Hansen, R.A. Petersen, D.K. Vanderveen The rod photoreceptors in retinopathy of prematurity: an electroretinographic study Arch Ophthalmol 119 2001 499 505
7. A.B. Fulton, R.M. Hansen Electroretinogram responses and refractive errors in patients with a history of retinopathy prematurity Doc Ophthalmol 91 1995 87 100
8. J.D. Akula, J.A. Mocko, A. Moskowitz, R.M. Hansen, A.B. Fulton The oscillatory potentials of the dark-adapted electroretinogram in retinopathy of prematurity Invest Ophthalmol Vis Sci 48 2007 5788 5797
9. N.N. Osborne, R.J. Casson, J.P. Wood, G. Chidlow, M. Graham, J. Melena Retinal ischemia: mechanisms of damage and potential therapeutic strategies Prog Retin Eye Res 23 2004 91 147
10. F. Dijk, A.A. Bergen, W. Kamphuis GAP-43 expression is upregulated in retinal ganglion cells after ischemia/reperfusion-induced damage Exp Eye Res 84 2007 858 867
11. Y. Aizu, K. Oyanagi, J. Hu, H. Nakagawa Degeneration of retinal neuronal processes and pigment epithelium in the early stage of the streptozotocin- diabetic rats Neuropathology 22 2002 161 170
12. M.J. Gastinger, R.S. Singh, A.J. Barber Loss of cholinergic and dopaminergic amacrine cells in streptozotocin-diabetic rat and Ins2Akita-diabetic mouse retinas Invest Ophthalmol Vis Sci 47 2006 3143 3150
13. L.E. Smith, E. Wesolowski, A. McLellan, S.K. Kostyk, R. D'Amato, R. Sullivan, P.A. D'Amore Oxygen-induced retinopathy in the mouse Invest Ophthalmol Vis Sci 35 1994 101 111
14. H. Ozaki, M.S. Seo, K. Ozaki, H. Yamada, E. Yamada, N. Okamoto, F. Hofmann, J.M. Wood, P.A. Campochiaro Blockade of vascular endothelial cell growth factor receptor signaling is sufficient to completely prevent retinal neovascularization Am J Pathol 156 2000 697 707
15. P. Pechan, H. Rubin, M. Lukason, J. Ardinger, E. DuFresne, W.W. Hauswirth, S.C. Wadsworth, A. Scaria Novel anti-VEGF chimeric molecules delivered by AAV vectors for inhibition of retinal neovascularization Gene Ther 16 2009 10 16
16. O. Konopatskaya, A.J. Churchill, S.J. Harper, D.O. Bates, T.A. Gardiner VEGF165b, an endogenous C-terminal splice variant of VEGF, inhibits retinal neovascularization in mice Mol Vis 12 2006 626 632
17. D. Watanabe, K. Suzuma, S. Matsui, M. Kurimoto, J. Kiryu, M. Kita, I. Suzuma, H. Ohashi, T. Ojima, T. Murakami, T. Kobayashi, S. Masuda, M. Nagao, N. Yoshimura, H. Takagi Erythropoietin as a retinal angiogenic factor in proliferative diabetic retinopathy N Engl J Med 353 2005 782 792
18. J. Chen, K.M. Connor, C.M. Aderman, K.L. Willett, O.P. Aspegren, L.E. Smith Suppression of retinal neovascularization by erythropoietin siRNA in a mouse model of proliferative retinopathy Invest Ophthalmol Vis Sci 50 2009 1329 1335
19. S.Q. Xiong, X.B. Xia, H.Z. Xu, J. Jiang Suppression of retinal neovascularization by small-interference RNA targeting erythropoietin Ophthalmologica 223 2009 306 312
20. J.D. Akula, R.M. Hansen, M.E. Martinez-Perez, A.B. Fulton Rod photoreceptor function predicts blood vessel abnormality in retinopathy of prematurity Invest Ophthalmol Vis Sci 48 2007 4351 4359
21. J.D. Akula, J.A. Mocko, I.Y. Benador, R.M. Hansen, T.L. Favazza, T.C. Vyhovsky, A.B. Fulton The neurovascular relation in oxygen-induced retinopathy Mol Vis 14 2008 2499 2508
22. X. Reynaud, R.M. Hansen, A.B. Fulton Effect of prior oxygen exposure on the electroretinographic responses of infant rats Invest Ophthalmol Vis Sci 36 1995 2071 2079
23. K.U. Eckardt, P.J. Ratcliffe, C.C. Tan, C. Bauer, A. Kurtz Age-dependent expression of the erythropoietin gene in rat liver and kidneys J Clin Invest 89 1992 753 760
24. X. Yu, J.J. Shacka, J.B. Eells, C. Suarez-Quian, R.M. Przygodzki, B. Beleslin-Cokic, C.S. Lin, V.M. Nikodem, B. Hempstead, K.C. Flanders, F. Costantini, C.T. Noguchi Erythropoietin receptor signalling is required for normal brain development Development 129 2002 505 516
25. J.C. Chavez, O. Baranova, J. Lin, P. Pichiule The transcriptional activator hypoxia inducible factor 2 (HIF-2/EPAS-1) regulates the oxygen-dependent expression of erythropoietin in cortical astrocytes J Neurosci 26 2006 9471 9481
26. C. Grimm, A. Wenzel, M. Groszer, H. Mayser, M. Seeliger, M. Samardzija, C. Bauer, M. Gassmann, C.E. Reme HIF-1-induced erythropoietin in the hypoxic retina protects against light-induced retinal degeneration Nat Med 8 2002 718 724
27. M. Morita, O. Ohneda, T. Yamashita, S. Takahashi, N. Suzuki, O. Nakajima, S. Kawauchi, M. Ema, S. Shibahara, T. Udono, K. Tomita, M. Tamai, K. Sogawa, M. Yamamoto, Y. Fujii-Kuriyama HLF/HIF-2alpha is a key factor in retinopathy of prematurity in association with erythropoietin EMBO J 22 2003 1134 1146
28. S.S. Shah, S.H. Tsang, V.B. Mahajan Erythropoetin receptor expression in the human diabetic retina BMC Res Notes 2 2009 234
29. A. Stahl, A. Buchwald, G. Martin, B. Junker, J. Chen, L.L. Hansen, H.T. Agostini, L.E. Smith, N. Feltgen Vitreal levels of erythropoietin are increased in patients with retinal vein occlusion and correlate with vitreal VEGF and the extent of macular edema Retina 30 2010 1524 1529
30. Y. Inomata, A. Hirata, E. Takahashi, T. Kawaji, M. Fukushima, H. Tanihara Elevated erythropoietin in vitreous with ischemic retinal diseases Neuroreport 15 2004 877 879
31. Y. Katsura, T. Okano, K. Matsuno, M. Osako, M. Kure, T. Watanabe, Y. Iwaki, M. Noritake, H. Kosano, H. Nishigori, T. Matsuoka Erythropoietin is highly elevated in vitreous fluid of patients with proliferative diabetic retinopathy Diabetes Care 28 2005 2252 2254
32. T. Sato, S. Kusaka, H. Shimojo, T. Fujikado Vitreous levels of erythropoietin and vascular endothelial growth factor in eyes with retinopathy of prematurity Ophthalmology 116 2009 1599 1603
33. J. Chen, K.M. Connor, C.M. Aderman, L.E. Smith Erythropoietin deficiency decreases vascular stability in mice J Clin Invest 118 2008 526 533
34. K.K. Suk, J.A. Dunbar, A. Liu, N.S. Daher, C.K. Leng, J.K. Leng, P. Lim, S. Weller, E. Fayard Human recombinant erythropoietin and the incidence of retinopathy of prematurity: a multiple regression model J AAPOS 12 2008 233 238
35. M. Saint-Geniez, A.S. Maharaj, T.E. Walshe, B.A. Tucker, E. Sekiyama, T. Kurihara, D.C. Darland, M.J. Young, P.A. D'Amore Endogenous VEGF is required for visual function: evidence for a survival role on muller cells and photoreceptors PLoS One 3 2008 e3554
36. K. Nishijima, Y.S. Ng, L. Zhong, J. Bradley, W. Schubert, N. Jo, J. Akita, S.J. Samuelsson, G.S. Robinson, A.P. Adamis, D.T. Shima Vascular endothelial growth factor-A is a survival factor for retinal neurons and a critical neuroprotectant during the adaptive response to ischemic injury Am J Pathol 171 2007 53 67
37. M.L. Brines, P. Ghezzi, S. Keenan, D. Agnello, N.C. de Lanerolle, C. Cerami, L.M. Itri, A. Cerami Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury Proc Natl Acad Sci USA 97 2000 10526 10531
38. A.K. Junk, A. Mammis, S.I. Savitz, M. Singh, S. Roth, S. Malhotra, P.S. Rosenbaum, A. Cerami, M. Brines, D.M. Rosenbaum Erythropoietin administration protects retinal neurons from acute ischemia-reperfusion injury Proc Natl Acad Sci USA 99 2002 10659 10664
39. C. Grimm, A. Wenzel, D. Stanescu, M. Samardzija, S. Hotop, M. Groszer, M. Naash, M. Gassmann, C. Remé Constitutive overexpression of human erythropoietin protects the mouse retina against induced but not inherited retinal degeneration J Neurosci 24 2004 5651 5658
40. C. Grimm, D.M. Hermann, A. Bogdanova, S. Hotop, U. Kilic, A. Wenzel, E. Kilic, M. Gassmann Neuroprotection by hypoxic preconditioning: HIF-1 and erythropoietin protect from retinal degeneration Semin Cell Dev Biol 16 2005 531 538
41. J.H. Weishaupt, G. Rohde, E. Plking, A.L. Siren, H. Ehrenreich, M. Bhr Effect of erythropoietin axotomy-induced apoptosis in rat retinal ganglion cells Invest Ophthalmol Vis Sci 45 2004 1514 1522
42. R. Bierer, M.C. Peceny, C.H. Hartenberger, R.K. Ohls Erythropoietin concentrations and neurodevelopmental outcome in preterm infants Pediatrics 118 2006 e635 e640
43. M.S. Brown, D. Eichorst, B. Lala-Black, R. Gonzalez Higher cumulative doses of erythropoietin and developmental outcomes in preterm infants Pediatrics 124 2009 e681 e687
44. P.H. Maxwell, M.K. Osmond, C.W. Pugh, A. Heryet, L.G. Nicholls, C.C. Tan, B.G. Doe, D.J. Ferguson, M.H. Johnson, P.J. Ratcliffe Identification of the renal erythropoietin-producing cells using transgenic mice Kidney Int 44 1993 1149 1162
45. K.B. Raja, P.H. Maxwell, P.J. Ratcliffe, J.R. Salisbury, R.J. Simpson, T.J. Peters Iron metabolism in transgenic mice with hypoplastic anaemia due to incomplete deficiency of erythropoietin Br J Haematol 96 1997 248 253
46. B. Lei, G. Yao, K. Zhang, K.J. Hofeldt, B. Chang Study of rod- and cone-driven oscillatory potentials in mice Invest Ophthalmol Vis Sci 47 2006 2732 2738
47. V.R. Krishna, K.R. Alexander, N.S. Peachey Temporal properties of the mouse cone electroretinogram J Neurophysiol 87 2002 42 48
48. T.A. Gardiner, D.S. Gibson, T.E. de Gooyer, V.F. de la Cruz, D.M. McDonald, A.W. Stitt Inhibition of tumor necrosis factor-alpha improves physiological angiogenesis and reduces pathological neovascularization in ischemic retinopathy Am J Pathol 166 2005 637 644
49. E. Banin, M.I. Dorrell, E. Aguilar, M.R. Ritter, C.M. Aderman, A.C. Smith, J. Friedlander, M. Friedlander T2-TrpRS inhibits preretinal neovascularization and enhances physiological vascular regrowth in OIR as assessed by a new method of quantification Invest Ophthalmol Vis Sci 47 2006 2125 2134
50. F.M. Mowat, U.F. Luhmann, A.J. Smith, C. Lange, Y. Duran, S. Harten, D. Shukla, P.H. Maxwell, R.R. Ali, J.W. Bainbridge HIF-1alpha and HIF-2alpha are differentially activated in distinct cell populations in retinal ischaemia PLoS One 5 2010 e11103
51. K. Shinoda, K. Yamada, C.S. Matsumoto, K. Kimoto, K. Nakatsuka Changes in retinal thickness are correlated with alterations of electroretinogram in eyes with central retinal artery occlusion Graefes Arch Clin Exp Ophthalmol 246 2008 949 954
52. R. Natoli, J. Provis, K. Valter, J. Stone Expression and role of the early-response gene Oxr1 in the hyperoxia-challenged mouse retina Invest Ophthalmol Vis Sci 49 2008 4561 4567
53. H. Yamada, E. Yamada, A. Ando, N. Esumi, N. Bora, J. Saikia, C.H. Sung, D.J. Zack, P.A. Campochiaro Fibroblast growth factor-2 decreases hyperoxia-induced photoreceptor cell death in mice Am J Pathol 159 2001 1113 1120
54. N. Walsh, A. Bravo-Nuevo, S. Geller, J. Stone Resistance of photoreceptors in the C57BL/6-c2J, C57BL/6J, and BALB/cJ mouse strains to oxygen stress: evidence of an oxygen phenotype Curr Eye Res 29 2004 441 447
55. J. Wellard, D. Lee, K. Valter, J. Stone Photoreceptors in the rat retina are specifically vulnerable to both hypoxia and hyperoxia Vis Neurosci 22 2005 501 507
56. D.M. Rosenbaum, P.S. Rosenbaum, H. Gupta, M. Singh, A. Aggarwal, D.H. Hall, S. Roth, J.A. Kessler The role of the p53 protein in the selective vulnerability of the inner retina to transient ischemia Invest Ophthalmol Vis Sci 39 1998 2132 2139
57. S. Mayor-Torroglosa, P. De la Villa, M.E. Rodrguez, M.P. López-Herrera, M. Avilés-Trigueros, A. Garca-Avilés, J.M. de Imperial, M.P. Villegas-Pérez, M. Vidal-Sanz Ischemia results 3 months later in altered ERG, degeneration of inner layers, and deafferented tectum: neuroprotection with brimonidine Invest Ophthalmol Vis Sci 46 2005 3825 3835
58. O. Dembinska, L.M. Rojas, D.R. Varma, S. Chemtob, P. Lachapelle Graded contribution of retinal maturation to the development of oxygen-induced retinopathy in rats Invest Ophthalmol Vis Sci 42 2001 1111 1118
59. D.Y. Yu, S.J. Cringle Oxygen distribution in the mouse retina Invest Ophthalmol Vis Sci 47 2006 1109 1112
60. D.Y. Yu, S.J. Cringle Oxygen distribution and consumption within the retina in vascularised and avascular retinas and in animal models of retinal disease Prog Retin Eye Res 20 2001 175 208
61. T. Alon, I. Hemo, A. Itin, J. Pe'er, J. Stone, E. Keshet Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity Nat Med 1 1995 1024 1028
62. J. Zhang, Y. Wu, Y. Jin, F. Ji, S.H. Sinclair, Y. Luo, G. Xu, L. Lu, W. Dai, M. Yanoff, W. Li, G.T. Xu Intravitreal injection of erythropoietin protects both retinal vascular and neuronal cells in early diabetes Invest Ophthalmol Vis Sci 49 2008 732 742
63. Z. Shao, A.L. Dorfman, S. Seshadri, M. Djavari, E. Kermorvant-Duchemin, F. Sennlaub, M. Blais, A. Polosa, D.R. Varma, J.S. Joyal, P. Lachapelle, P. Hardy, N. Sitaras, E. Picard, J. Mancini, P. Sapieha, S. Chemtob Choroidal involution is a key component of oxygen induced retinopathy Invest Ophthalmol Vis Sci 52 2011 6238 6248
64. J.D. Slusarski, R.J. McPherson, G.N. Wallace, S.E. Juul High-dose erythropoietin does not exacerbate retinopathy of prematurity in rats Pediatr Res 66 2009 625 630
65. C.M. McVicar, L.M. Colhoun, J.L. Abrahams, C.L. Kitson, R. Hamilton, R.J. Medina, D. Durga, T.A. Gardiner, P.M. Rudd, A.W. Stitt Differential modulation of angiogenesis by erythropoiesis-stimulating agents in a mouse model of ischaemic retinopathy PLoS One 5 2010 e11870
66. N. Kertesz, J. Wu, T.H. Chen, H.M. Sucov, H. Wu The role of erythropoietin in regulating angiogenesis Dev Biol 276 2004 101 110
67. L. Zhong, J. Bradley, W. Schubert, E. Ahmed, A.P. Adamis, D.T. Shima, G.S. Robinson, Y.S. Ng Erythropoietin promotes survival of retinal ganglion cells in DBA/2J glaucoma mice Invest Ophthalmol Vis Sci 48 2007 1212 1218
68. K. Krgel, A. Wurm, R. Linnertz, T. Pannicke, P. Wiedemann, A. Reichenbach, A. Bringmann Erythropoietin inhibits osmotic swelling of retinal glial cells by Janus kinase- and extracellular signal-regulated kinases1/2-mediated release of vascular endothelial growth factor Neuroscience 165 2010 1147 1158
69. J.C. Dreixler, S. Hagevik, J.W. Hemmert, A.R. Shaikh, D.M. Rosenbaum, S. Roth Involvement of erythropoietin in retinal ischemic preconditioning Anesthesiology 110 2009 774 780
70. R.A. Linsenmeier Electrophysiological consequences of retinal hypoxia Graefes Arch Clin Exp Ophthalmol 228 1990 143 150
71. T.S. Rex, M. Allocca, L. Domenici, E.M. Surace, A.M. Maguire, A. Lyubarsky, A. Cellerino, J. Bennett, A. Auricchio Systemic but not intraocular Epo gene transfer protects the retina from light-and genetic-induced degeneration Mol Ther 10 2004 855 861
72. C.M. McVicar, R. Hamilton, L.M. Colhoun, T.A. Gardiner, M. Brines, A. Cerami, A.W. Stitt Intervention with an erythropoietin-derived peptide protects against neuroglial and vascular degeneration during diabetic retinopathy Diabetes 60 2011 2995 3005
73. H. Wilms, B. Schwabedissen, J. Sievers, R. Lucius Erythropoietin does not attenuate cytokine production and inflammation in microgliaimplications for the neuroprotective effect of erythropoietin in neurological diseases J Neuroimmunol 212 2009 106 111
74. M. Sasahara, A. Otani, A. Oishi, H. Kojima, Y. Yodoi, T. Kameda, H. Nakamura, N. Yoshimura Activation of bone marrow-derived microglia promotes photoreceptor survival in inherited retinal degeneration Am J Pathol 172 2008 1693 1703
75. J.K. Schneider, D.K. Gardner, L. Cordero Use of recombinant human erythropoietin and risk of severe retinopathy in extremely low-birth-weight infants Pharmacotherapy 28 2008 1335 1340